Canadian Sec - Delayed Quote CAD

Biosenta Inc. (ZRO.CN)

0.1300
0.0000
(0.00%)
At close: May 2 at 9:30:00 AM EDT
Loading Chart for ZRO.CN
  • Previous Close 0.1300
  • Open 0.0000
  • Bid --
  • Ask 0.1500 x --
  • Day's Range 0.1300 - 0.1300
  • 52 Week Range 0.0550 - 0.4900
  • Volume 0
  • Avg. Volume 1,889
  • Market Cap (intraday) 4.267M
  • Beta (5Y Monthly) 0.51
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0800
  • Earnings Date May 27, 2025 - Jun 2, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Biosenta Inc. develops, manufactures, and sells chemical compounds for household and industrial applications in Canada. The company develops True, an anti-microbial, dual-action disinfectant for destroying viruses, bacteria, germs, molds, and fungi. It also manufactures and distributes Tri-Filler, an anti-microbial filler to perform filling and bulking functions. Biosenta Inc. was incorporated in 1986 and is based in Toronto, Canada.

www.biosenta.com

--

Full Time Employees

September 30

Fiscal Year Ends

Recent News: ZRO.CN

View More

Performance Overview: ZRO.CN

Trailing total returns as of 5/9/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index (^GSPTSE) .

YTD Return

ZRO.CN
50.00%
S&P/TSX Composite index (^GSPTSE)
2.99%

1-Year Return

ZRO.CN
73.47%
S&P/TSX Composite index (^GSPTSE)
13.33%

3-Year Return

ZRO.CN
74.00%
S&P/TSX Composite index (^GSPTSE)
26.79%

5-Year Return

ZRO.CN
160.00%
S&P/TSX Composite index (^GSPTSE)
69.43%

Compare To: ZRO.CN

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ZRO.CN

View More

Valuation Measures

As of 5/9/2025
  • Market Cap

    4.27M

  • Enterprise Value

    10.16M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    2.42k

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    6.08k

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -321.17%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    1.67k

  • Net Income Avi to Common (ttm)

    -2.34M

  • Diluted EPS (ttm)

    -0.0800

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    45.49k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -1.06M

Research Analysis: ZRO.CN

View More

People Also Watch